Re: Aducanumab-Related ARIA: Paean or Lament?

Clin Nucl Med. 2023 Jun 1;48(6):505-506. doi: 10.1097/RLU.0000000000004509. Epub 2023 Feb 1.

Authors

Poul F Høilund-Carlsen, Abass Alavi¹, Mona-Elisabeth Revheim²

Affiliations

¹ Department of Radiology Hospital of the University of Pennsylvania Philadelphia, PA.
² Division of Radiology and Nuclear Medicine Oslo University Hospital; Institute of Clinical Medicine, University of Oslo Oslo, Norway [email protected] ; [email protected].

No abstract available

Publication types

Letter
Comment

MeSH terms

Alzheimer Disease*
Amyloid beta-Peptides
Antibodies, Monoclonal, Humanized* / adverse effects
Humans

Substances

aducanumab
Antibodies, Monoclonal, Humanized
Amyloid beta-Peptides